New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Atezolizumab can induce response in alveolar soft part sarcoma

Atezolizumab can induce response in alveolar soft part sarcoma

by Elana GotkineThe immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according to a study published in the S
World medicine December 05,2023
Atezolizumab can induce response in alveolar soft part sarcoma

Atezolizumab can induce response in alveolar soft part sarcoma

by Elana GotkineThe immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according to a study published in the S
World medicine December 05,2023
Atezolizumab monotherapy beneficial for non-small cell lung cancer ineligible for platinum-based chemo

Atezolizumab monotherapy beneficial for non-small cell lung cancer ineligible for platinum-based chemo

by Elana GotkineFor patients with non-small cell lung cancer (NSCLC) ineligible for platinum-based chemotherapy, first-line atezolizumab monotherapy is associated with improved overall survival compar
World medicine December 05,2023
Atezolizumab monotherapy beneficial for non-small cell lung cancer ineligible for platinum-based chemo

Atezolizumab monotherapy beneficial for non-small cell lung cancer ineligible for platinum-based chemo

by Elana GotkineFor patients with non-small cell lung cancer (NSCLC) ineligible for platinum-based chemotherapy, first-line atezolizumab monotherapy is associated with improved overall survival compar
World medicine December 05,2023
ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainHER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with treatment-refrac
World medicine December 05,2023
ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainHER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with treatment-refrac
World medicine December 05,2023
AI predicts future pancreatic cancer

AI predicts future pancreatic cancer

byHarvard Medical SchoolTraining and prediction of pancreatic cancer risk from disease trajectories.a, Learning: The general ML workflow starts with partitioning the data into a training s
World medicine December 05,2023
AI predicts future pancreatic cancer

AI predicts future pancreatic cancer

byHarvard Medical SchoolTraining and prediction of pancreatic cancer risk from disease trajectories.a, Learning: The general ML workflow starts with partitioning the data into a training s
World medicine December 05,2023
AI helps identify cancer risk factors

AI helps identify cancer risk factors

byUniversity of South AustraliaFeature importance summary and key features associated with cancer risk. (A) Feature importance of 84 important features identified using GBDT-SHAP pipeline, with
World medicine December 05,2023
AI helps identify cancer risk factors

AI helps identify cancer risk factors

byUniversity of South AustraliaFeature importance summary and key features associated with cancer risk. (A) Feature importance of 84 important features identified using GBDT-SHAP pipeline, with
World medicine December 05,2023
AGO2 in T-prolymphocytic leukemia (T-PLL)

AGO2 in T-prolymphocytic leukemia (T-PLL)

by Impact Journals LLCScheme of mechanisms of AGO2 (de)regulation and its (novel) functions in T-PLL. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28378A new editorial paper titled &q
World medicine December 05,2023
AGO2 in T-prolymphocytic leukemia (T-PLL)

AGO2 in T-prolymphocytic leukemia (T-PLL)

by Impact Journals LLCScheme of mechanisms of AGO2 (de)regulation and its (novel) functions in T-PLL. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28378A new editorial paper titled &q
World medicine December 05,2023
ACSL4: Biomarker, mediator and target in quadruple negative breast cancer

ACSL4: Biomarker, mediator and target in quadruple negative breast cancer

by Impact Journals LLCProposed pathway of ACSL4-mediated stimulation of quadruple negative breast cancer cells. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28453A new review paper ti
World medicine December 05,2023
ACSL4: Biomarker, mediator and target in quadruple negative breast cancer

ACSL4: Biomarker, mediator and target in quadruple negative breast cancer

by Impact Journals LLCProposed pathway of ACSL4-mediated stimulation of quadruple negative breast cancer cells. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28453A new review paper ti
World medicine December 05,2023
Cannabis Products to Reduce Cancer Symptoms in Children: Is It Safe?

Cannabis Products to Reduce Cancer Symptoms in Children: Is It Safe?

byHemalatha Manikandanon August 29, 2023Cannabisproducts have gained popularity among patients and families for managingcancersymptoms such as pain,anxiety, and&nbs
World medicine December 05,2023
Cannabis Products to Reduce Cancer Symptoms in Children: Is It Safe?

Cannabis Products to Reduce Cancer Symptoms in Children: Is It Safe?

byHemalatha Manikandanon August 29, 2023Cannabisproducts have gained popularity among patients and families for managingcancersymptoms such as pain,anxiety, and&nbs
World medicine December 05,2023
Exercise to Fight Side-effects of Prostate Cancer

Exercise to Fight Side-effects of Prostate Cancer

byHemalatha Manikandanon August 30, 2023Exerciseor physical activity was revealed to combat the side effects of prostate cancer, especially sexual dysfunction. This clinical trial wa
World medicine December 05,2023
Exercise to Fight Side-effects of Prostate Cancer

Exercise to Fight Side-effects of Prostate Cancer

byHemalatha Manikandanon August 30, 2023Exerciseor physical activity was revealed to combat the side effects of prostate cancer, especially sexual dysfunction. This clinical trial wa
World medicine December 05,2023
Promise of Pyrvinium, the antihelminthic Drug in Stomach Cancer Prevention

Promise of Pyrvinium, the antihelminthic Drug in Stomach Cancer Prevention

byColleen Fleisson October 7, 2023Pyrvinium, a medication traditionally employed for intestinal pinworms over the course of several decades, holds potential for repurposing as a preventive
World medicine December 05,2023
Promise of Pyrvinium, the antihelminthic Drug in Stomach Cancer Prevention

Promise of Pyrvinium, the antihelminthic Drug in Stomach Cancer Prevention

byColleen Fleisson October 7, 2023Pyrvinium, a medication traditionally employed for intestinal pinworms over the course of several decades, holds potential for repurposing as a preventive
World medicine December 05,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com